Latest news with #CA-based
Yahoo
3 days ago
- Business
- Yahoo
Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum. For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates. Alameda, CA-based Exelixis, Inc. is an oncology-focused biotechnology company that primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. The company is leveraging its investments, expertise and strategic partnerships to target an expanding range of tumor types and indications with its clinically differentiated pipeline of small molecules, antibody-drug conjugates (ADCs) and other biotherapeutics. EXEL sits at a Zacks Rank #2 (Buy), holds a Momentum Style Score of A, and has a VGM Score of A. The stock is down 1% and up 15.8% over the past one-week and four-week period, respectively, and Exelixis has gained 96.3% in the last one-year period as well. Additionally, an average of 3,878,287.25 shares were traded over the last 20 trading sessions. A company's earnings performance is important for momentum investors as well. For fiscal 2025, nine analysts revised their earnings estimate higher in the last 60 days for EXEL, while the Zacks Consensus Estimate has increased $0.26 to $2.57 per share. EXEL also boasts an average earnings surprise of 48.6%. Investors should take the time to consider EXEL for their portfolios due to its solid Zacks Ranks, notable earnings metrics, and impressive Momentum and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelixis, Inc. (EXEL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
Mission Produce Pre-Q2 Earnings Review: Buy Now or Stay Cautious?
Mission Produce Inc. AVO is likely to witness top and bottom-line declines when it reports second-quarter fiscal 2025 results on June 5, after market close. The Zacks Consensus Estimate for fiscal second-quarter sales is pegged at $282.1 million, indicating a 5.2% decrease from the year-ago quarter's reported consensus estimate for the company's fiscal second-quarter earnings is pegged at 3 cents per share, suggesting a 78.6% decline from the year-ago quarter's actual. Earnings estimates have been unchanged in the past 30 days. (See the Zacks Earnings Calendar to stay ahead of market-making news.)The Oxnard, CA-based company has been reporting steady earnings outcomes, as evident from its top and bottom-line surprise trends in the trailing three quarters. Mission Produce delivered an earnings surprise of 900% in the last reported quarter. Given its positive record, the question is, can AVO maintain the momentum? Our proven model does not conclusively predict an earnings beat for AVO this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Produce has an Earnings ESP of 0.00% and a Zacks Rank of 3. You can see the complete list of today's Zacks #1 Rank stocks here. Mission Produce is expected to have sustained its growth momentum in second-quarter fiscal 2025, underpinned by resilient global demand, strategic diversification and strong operational agility. The rise in avocado consumption, fueled by health-conscious consumer trends and growing popularity in emerging markets, is expected to continue supporting AVO's international farming model. Additionally, optimized distribution channels position it to capitalize on these enduring short-term challenges, such as supply shifts in Mexico, may create volatility, Mission Produce's proactive diversification, operational discipline and strategic foresight offer a strong foundation for sustained growth and profitability. This is expected to have bolstered the second-quarter fiscal 2025 top line and volumes. Mission Produce, Inc. price-eps-surprise | Mission Produce, Inc. Quote On the last reported quarter's earnings call, the company projected the avocado industry volumes to remain consistent year over year, with Mexican supply tapering due to a lighter-than-expected harvest. However, this is likely to be offset by a faster-than-usual ramp-up in California and Peru's crop, aided by favorable weather. This dynamic is expected to support a 5% year-over-year increase in average avocado pricing in the fiscal second quarter, signaling robust demand despite inflationary Blueberry segment is also on track for a strong performance, with total harvest volumes projected to rise 35-40% in second-quarter fiscal 2025, driven by expanded acreage and improved yields. Approximately 20% of the Peruvian crop is expected to be sold in the quarter, aligning with last year's seasonal cycle. While average prices may decline sequentially, they are projected to remain in line with second-quarter fiscal 2024, reflecting a normalized supply-demand environment and healthy production Mission Produce's ongoing investments in vertical integration, digital innovation and geographic diversification are expected to improve operational efficiency and asset utilization, particularly in its International Farming segment. This sets the stage for longer-term margin recovery despite near-term cost pressures and tariff uncertainties. Mission Produce's shares have exhibited a downtrend in the past three months, losing 9.4% against the industry's growth of 1.5%. Meanwhile, the company has underperformed the Zacks Consumer Staples sector and the S&P 500's growth of 9.3% and 1%, respectively. Image Source: Zacks Investment Research AVO stock has also underperformed industry peers, including Archer Daniels Midland Company ADM, Corteva Inc. CTVA and Calavo Growers CVGW, which rallied 3.7%, 17.3% and 21%, respectively, in the past three its current price of $11.18, the AVO stock trades 17.2% above its 52-week low of $6.54. Moreover, Mission Produce's current stock price stands 26.7% below its 52-week high of $ the valuation standpoint, the company trades at a forward 12-month P/E multiple of 27.78X, exceeding the industry average of 15.55X and the S&P 500's average of premium valuation suggests that investors have strong expectations for Mission Produce's future performance and growth potential. However, the stock currently seems somewhat overvalued. As a result, investors may be hesitant to buy at these elevated levels and prefer to wait for a more favorable entry point. Image Source: Zacks Investment Research Mission Produce continues to cement its position as a global leader in the avocado industry, attracting investor interest with its scale, strategic clarity and consistent execution. AVO leans on a vertically integrated, global footprint with a sharp focus on operational efficiency and international sourcing. With sourcing operations across Mexico, Peru, Colombia and Guatemala, AVO commands a meaningful share of the global avocado supply and is steadily expanding into complementary high-growth categories like blueberries and tariff uncertainties remain a variable, especially given Mexico's central role in sourcing. Temporary tariffs earlier this year created margin pressure and underscored the value of Mission Produce's global diversification. With alternative sourcing regions like Peru, Colombia and others, and a resilient supply network, the company is well-equipped to absorb geopolitical shocks, strengthening its case as a long-term growth player in the global produce sector. Regardless of how Mission Produce's stock responds to its second-quarter fiscal 2025 results, the company's long-term growth narrative remains compelling. The company's vertically integrated model, diversified sourcing and expanding multi-category portfolio, anchored by health-forward staples, position it well to benefit from enduring consumer demand trends. While near-term headwinds like inflation, high interest rates and tariff uncertainties may weigh on margins, these pressures appear cyclical rather than the financial front, AVO is delivering disciplined, profitable growth, with improvements in adjusted earnings and EBITDA, driven by strong asset utilization and expanding farming operations. Investments in digital innovation are further streamlining logistics and supply-chain efficiency. While some investors may wait for a more attractive valuation, long-term holders can remain confident. The company's strategic execution and innovation are well-aligned to deliver sustained value over time. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Archer Daniels Midland Company (ADM) : Free Stock Analysis Report Calavo Growers, Inc. (CVGW) : Free Stock Analysis Report Corteva, Inc. (CTVA) : Free Stock Analysis Report Mission Produce, Inc. (AVO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
Here's Why Exelixis (EXEL) is a Strong Growth Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term. For growth investors, a company's financial strength, overall health, and future outlook take precedence, so they'll want to zero in on the Growth Style Score. This Score examines things like projected and historical earnings, sales, and cash flow to find stocks that will generate sustainable growth over time. Alameda, CA-based Exelixis, Inc. is an oncology-focused biotechnology company that primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. The company is leveraging its investments, expertise and strategic partnerships to target an expanding range of tumor types and indications with its clinically differentiated pipeline of small molecules, antibody-drug conjugates (ADCs) and other biotherapeutics. EXEL is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of A. Earnings are expected to grow 28.5% year-over-year for the current fiscal year, with sales growth of 7.2%. Nine analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.26 to $2.57 per share for 2025. EXEL boasts an average earnings surprise of 48.6%. Looking at cash flow, Exelixis is expected to report cash flow growth of 135.6% this year; EXEL has generated cash flow growth of 10.8% over the past three to five years. Investors should take the time to consider EXEL for their portfolios due to its solid Zacks Rank rating, notable growth metrics, and impressive Growth and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelixis, Inc. (EXEL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
26-05-2025
- Business
- Yahoo
Cautious Optimism in Gap's Pre-Q1 Earnings: Buy or Hold for Now?
The Gap, Inc. GAP is expected to register top and bottom-line growth when it reports first-quarter fiscal 2025 results on May 29, after the closing bell. For revenues, the Zacks Consensus Estimate is pegged at $3.4 billion, indicating a 0.9% rise from the year-ago quarter's reported Zacks Consensus Estimate for fiscal first-quarter earnings is pegged at 44 cents per share, suggesting a 7.3% increase from the year-ago quarter's reported figure. The consensus estimate for fiscal first-quarter earnings has moved up by a penny in the past 30 days. (See the Zacks Earnings Calendar to stay ahead of market-making news.)The San Francisco, CA-based company has been reporting steady earnings outcomes, as evident from its positive top and bottom-line surprise trends in the trailing four quarters. In the last reported quarter, the company's earnings beat the Zacks Consensus Estimate by 50%. GAP has a trailing four-quarter earnings surprise of 77.5%, on average. Given its positive record, the question is whether the stock can maintain its momentum. Our proven model conclusively predicts an earnings beat for GAP this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks before they are reported with our Earnings ESP currently has an Earnings ESP of +3.03% and a Zacks Rank #3. You can see the complete list of today's Zacks #1 Rank stocks here. Gap's first-quarter fiscal 2025 results are expected to reflect its ability to gain market share and revive its brand position. Management has been committed to creating a trend-right merchandise assortment, deepening relations with customers via marketing, enhancing the digital commerce agenda and efficiently controlling expenses. Gains from these actions are expected to have bolstered the company's performance in first-quarter fiscal first-quarter fiscal 2025 results are expected to benefit from its strong execution, brand momentum and financial discipline, positioning it for sustained growth. As a longstanding force in the apparel industry, Gap maintains a significant market presence through its diverse brand portfolio, which includes Old Navy, Banana Republic and the last reported quarter's earnings call, Gap anticipated net sales to be flat to up slightly year over year for the first quarter of fiscal 2025, signaling confidence in its strategic roadmap despite ongoing macroeconomic challenges. Sales growth is expected to be led by Old Navy and Gap brands, with Banana Republic showing signs of stabilization and Athleta undergoing a measured has been focused on enhancing supply-chain efficiency, implementing cost-saving strategies and driving digital transformation to improve operational agility and customer experience. At the same time, investments in product innovation, sustainability efforts and high-profile collaborations have helped attract younger consumers and reinforce the brand's cultural relevance. International expansion and accelerated e-commerce adoption strengthen Gap's long-term positioning. The Gap, Inc. price-eps-surprise | The Gap, Inc. Quote GAP is driving meaningful cost efficiencies, targeting $150 million in cost savings in fiscal 2025, a portion of which will be reinvested in growth initiatives. These cost-savings are expected to have bolstered margins in the to-be-reported persistent headwinds, including inflation and tariff uncertainty, management has been preparing for a dynamic and resilient fiscal 2025. On the tariff front, the company has proactively diversified its sourcing. In fiscal 2024, fewer than 10% of its products were sourced from China, with Canada and Mexico representing less than 1% combined. As a result, Gap expects only a limited impact on margins from recently imposed tariffs, reflecting prudent supply-chain the fiscal first quarter, the company expects the gross margin to rise slightly year over year from the 41.2% recorded in the prior-year quarter. SG&A is expected to leverage marginally in the fiscal first quarter. Operating expenses, as a percentage of sales, are anticipated to leverage slightly year over expect the adjusted gross margin to jump 10 bps and adjusted operating expenses, as a percentage of sales, to dip 30 bps year over year for the fiscal first quarter. Our model indicates an increase of 30 bps in the adjusted operating margin to 6.4% in the to-be-reported quarter. GAP's shares have exhibited an uptrend in the past year, leaving behind its industry peers and the S&P 500. In the past year, the apparel retailer's shares have rallied 35.7%, outperforming the industry's decline of 0.1%. Also, the stock has outpaced the sector and the S&P 500's growth of 16% and 9.4%, respectively, in the same Gap stock has displayed a significant rally compared with American Eagle Outfitters Inc. AEO, Abercrombie & Fitch ANF and Canada Goose's GOOS slumps of 53.8%, 51.2% and 15.8%, respectively, in the past year. Image Source: Zacks Investment Research At the current price of $28.46, the stock trades 7% below its 52-week high of $30.59. The company trades 67.5% above its 52-week low mark of $ a valuation perspective, Gap shares present an attractive opportunity, trading at a discount to industry benchmarks. With a forward 12-month price-to-earnings ratio of 12.01X, below the Retail - Apparel and Shoes industry's average of 17.68X, the stock offers compelling value for investors seeking exposure to the sector. The stock currently has a Value Score of A, validating its appeal. Image Source: Zacks Investment Research Gap has solidified its market presence through a portfolio of four distinct brands — Gap, Old Navy, Banana Republic and Athleta — each strategically targeting different consumer segments and contributing to a well-diversified revenue base. The company's recent turnaround underscores the resilience of its business model and the impacts of disciplined cost for long-term growth, GAP is focused on delivering trend-forward assortments, strengthening customer engagement through strategic marketing, accelerating its digital commerce initiatives and driving operational efficiency. By leveraging its strong retail legacy and iconic brand lineup, the company is actively executing key priorities to remain competitive and relevant in an evolving retail environment. Gap heads into its first-quarter fiscal 2025 earnings results with cautious optimism, backed by disciplined cost control, brand diversification and strategic execution. While macroeconomic headwinds and tariff uncertainties persist, the company's efforts to streamline operations, modernize its merchandise mix, and deepen customer engagement appear to be yielding incremental a modest improvement in margins expected and solid contributions anticipated from key brands like Old Navy and Gap, the stage is set for a potentially stable performance in the fiscal first quarter. However, given the broader retail landscape's ongoing volatility, investors may want to temper expectations and closely monitor management's commentary on full-year guidance and brand momentum before making any definitive moves. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abercrombie & Fitch Company (ANF) : Free Stock Analysis Report American Eagle Outfitters, Inc. (AEO) : Free Stock Analysis Report The Gap, Inc. (GAP) : Free Stock Analysis Report Canada Goose Holdings Inc. (GOOS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23-05-2025
- Business
- Yahoo
Walt Disney (DIS) Boasts Earnings & Price Momentum: Should You Buy?
Kickstarting your investment journey can be both exciting and scary at the same time, and if you're new to investing, you may not know where to even begin. However, one thing is for certain -- stocks set to beat the market over the next 12 months serve as the perfect foundation for any kind of investor. Now, let's take a deep dive into a great stock that could be just the right addition to your portfolio. Burbank, CA-based Walt Disney Company has assets that span movies, television shows and theme parks. Revenues were $91.4 billion in fiscal 2024. DIS was added to the Zacks Focus List on March 23, 2020 at $85.98 per share. Since then, shares have increased 29.25% to $111.13. Eight analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.24 to $5.72. DIS boasts an average earnings surprise of 16.4%. Earnings for Walt Disney are forecasted to see growth of 15.1% for the current fiscal year as well. Because stock prices react to revisions, buying stocks with rising earnings estimates can be very profitable. Focus List stocks like DIS offer investors a great opportunity to get into a company whose future earnings estimates will be raised, potentially leading to price momentum. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Walt Disney Company (DIS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
